Martin Vander Weyer

Martin Vander Weyer

Martin Vander Weyer is business editor of The Spectator. He writes the weekly Any Other Business column.

We’re probably all on Mossack Fonseca’s books

From our UK edition

Let me make this perfectly clear: I have never asked Mossack Fonseca of Panama to set up a company for me in the British Virgin Islands or anywhere else. At least I don’t think I have: I mean, who reads the small print of all that boring paperwork from wealth managers and accountants these days?

Pay packets, profits and promotions

From our UK edition

I usually take a stern view of corporate pay packets that are out of line with profits and shareholder value, but I’m prepared to make an exception for Bob Dudley. The American-born chief executive of BP collected $19.6 million last year, up 20 per cent on his 2014 remuneration, while the embattled oil giant clocked up

The Budget: what to expect from the Chancellor

From our UK edition

What’s in next week’s budget? Not much, apparently. ‘Cabinet sources’ have been quoted saying that ‘George has been told not to rock the boat’ ahead of the Brexit referendum, and that’s why he backed away from a grab on pension relief for higher earners; likewise he may yield to pressure from his backbenchers not to

Sell the London Stock Exchange? OK, but not to the Germans

From our UK edition

The London Stock Exchange is no longer the red-hot crucible it once was, given the multifarious ways by which shares, bonds and derivatives now change hands. But the prospect of the LSE passing into the control of Deutsche Börse — in what was announced as a ‘merger of equals’, but with the Germans holding the

Mr Bear is back: sit tight because he may be with us for a while

From our UK edition

Like Leonardo DiCaprio in The Revenant, we’ve just been savaged by a bear but we’ll probably survive. Leading UK-listed stocks have fallen 20 per cent from last April’s peak after a six-year climb, and the FTSE100 chart has taken on a saw-toothed downward trajectory that suggests, to those who rely on such indicators, that there

The human element: highs, lows and loose ends of 2015

From our UK edition

Last year was a bumper year for mergers and acquisitions. Recovering prospects and relatively low price-earnings ratios made the takeover arena alluring: the global volume of deals looks certain to have passed the $4.3 trillion record of 2007. Among the new giants are Shell-BG, Heinz-Kraft, Pfizer-Allergan and monster brewer AB InBev-SAB Miller; bonuses reaped by London